Why are combination drugs in India being banned episode artwork

EPISODE · Aug 30, 2024 · 33 MIN

Why are combination drugs in India being banned

from In Focus by The Hindu · host The Hindu

The Central government, a few days ago, banned 156 fixed dose combination drugs, or FDCs. An FDC is a drug that has more than one active ingredient – two or more drugs together, in a single pill, capsule or shot. This is the latest in a series of bans brought in by the Centre – last year 14 FDCs were banned, and a total of 499 have been banned since 2014.  Why is this happening? Expert committees of the government have said these FDCs are irrational or have no therapeutic value for patients. In fact, FDCs are known to contribute to a growing public health problem in India – antimicrobial resistance So then why is the Indian market dominated by FDCs? Why are there FDCs in India that are not found anywhere else in the world? How are even unapproved and banned FDCs often found in the market? Guest: S Srinivasan, co-convenor, All India Drug Action Network Host: Zubeda Hamid Edited by Jude Francis Weston Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode metadata supplied by the publisher feed · Published Aug 30, 2024

Embed this episode

NOW PLAYING

Why are combination drugs in India being banned

0:00 33:25

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of In Focus by The Hindu?

This episode is 33 minutes long.

When was this In Focus by The Hindu episode published?

This episode was published on August 30, 2024.

Can I download this In Focus by The Hindu episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!